Row over SMA drug distribution in Keralam unwarranted, say experts
Experts say the dispute over the distribution of a spinal muscular atrophy medication in Kerala is unnecessary. Parents alleged that the free drug provided at a state hospital was experimental, but officials clarified it was a generic form of Risdiplam, originally patented by Roche and now produced by Natco Pharma, which has received approval from Indian drug regulators.